| scholarly article | Q13442814 |
| P2093 | author name string | N Mehrabi | |
| A Ansarymoghadam | |||
| H Poustchi | |||
| S Esmaili | |||
| Sg Sepanlou | |||
| P2860 | cites work | Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors | Q27490493 |
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Changing incidence of hepatocellular carcinoma in Japan | Q70191045 | ||
| Global programme for control of hepatitis B infection | Q71772495 | ||
| Hepatitis C and Hepatocellular Carcinoma | Q71837034 | ||
| Hepatocellular carcinoma | Q73254727 | ||
| A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group | Q73315497 | ||
| Hepatitis C--global prevalence (update) | Q73379666 | ||
| [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution] | Q73602638 | ||
| Increase in primary liver cancer in the UK, 1979–94 | Q73818313 | ||
| Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran | Q74664390 | ||
| Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study | Q80947628 | ||
| Hepatocellular carcinoma | Q93954853 | ||
| A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis | Q45850121 | ||
| Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans | Q46506267 | ||
| Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease | Q46571730 | ||
| Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4. | Q50580303 | ||
| Cancer occurrence in Iran in 2002, an international perspective. | Q53265301 | ||
| Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. | Q53330752 | ||
| Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer | Q53548540 | ||
| Hepatitis B carriers in large vehicle drivers of Iran | Q56864504 | ||
| Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960 | Q56994892 | ||
| Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran | Q57157459 | ||
| Epidemiology of Hepatocellular Carcinoma | Q58296509 | ||
| Oral contraceptive use and liver cancer | Q69359515 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
| Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium | Q29619747 | ||
| Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries | Q31049050 | ||
| Molecular epidemiology of human cancer | Q33533997 | ||
| Epidemiology of primary liver cancer | Q33750533 | ||
| Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia | Q33865899 | ||
| Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival | Q33866812 | ||
| Changing international trends in mortality rates for liver, biliary and pancreatic tumours | Q33962674 | ||
| Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. | Q33982107 | ||
| Hepatitis C virus infection: 10 years after the discovery of the virus | Q34276294 | ||
| Oral contraceptives and hepatocellular carcinoma | Q34286033 | ||
| Cancer burden in the year 2000. The global picture | Q34402117 | ||
| Hepatocellular carcinoma: from gene to public health. | Q34450751 | ||
| Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. | Q34502680 | ||
| Hepatocellular carcinoma: an epidemiologic view | Q34528348 | ||
| Hepatocellular carcinoma and hepatitis C in the United States | Q34528514 | ||
| Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. | Q34561668 | ||
| Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa | Q34567312 | ||
| Global cancer statistics in the year 2000. | Q34571897 | ||
| Hepatitis C virus genotypes in Saudi Arabia. | Q34591448 | ||
| Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry | Q34769250 | ||
| Epidemiology and clinical aspects on hepatitis C. | Q34795968 | ||
| Hepatocellular carcinoma: present status and future prospects | Q35068060 | ||
| Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication | Q35867756 | ||
| Epidemiology of hepatitis B virus infection in the Middle East. | Q35872901 | ||
| Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water | Q35994544 | ||
| Hepatocellular carcinoma. A worldwide problem and the major risk factors | Q36401904 | ||
| The association of complex liver disorders with HBV genotypes prevalent in Pakistan | Q36402124 | ||
| Distribution of hepatitis C virus genotypes in the Middle East | Q36431811 | ||
| Immunology of hepatitis C virus infection | Q36619059 | ||
| Chronic hepatitis C treatment: a review | Q36722975 | ||
| Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention | Q37112289 | ||
| Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. | Q37347303 | ||
| Cancer epidemiology and control in the arab world - past, present and future. | Q37495916 | ||
| Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma | Q38854669 | ||
| Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. | Q38855426 | ||
| The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients | Q39053876 | ||
| Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease | Q39191917 | ||
| Hepatitis B virus. The major etiology of hepatocellular carcinoma | Q39199064 | ||
| Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single center experience | Q39378220 | ||
| Genetic epidemiology of hepatitis C virus throughout egypt | Q39387214 | ||
| Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995. | Q39481034 | ||
| The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. | Q39882892 | ||
| Seroprevalence of hepatitis C virus: the first population-based study from Iran | Q39886309 | ||
| Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B | Q39919353 | ||
| Modeling the hepatitis C virus epidemic in France | Q40816221 | ||
| Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease. | Q41012219 | ||
| Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. | Q42634365 | ||
| Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients | Q42642801 | ||
| Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. | Q42658570 | ||
| Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin | Q42982219 | ||
| Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan) | Q42984684 | ||
| A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma | Q42986473 | ||
| Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region | Q42987165 | ||
| Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients | Q42988437 | ||
| Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes | Q42990556 | ||
| Hepatitis C genotypes and subtypes in Saudi Arabia | Q42993288 | ||
| Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study | Q42993513 | ||
| Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia | Q42997252 | ||
| Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study | Q42999098 | ||
| Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan | Q43037379 | ||
| Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics | Q43038388 | ||
| Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping | Q43039448 | ||
| Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study | Q43039669 | ||
| Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group | Q43040410 | ||
| Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients | Q43040870 | ||
| Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. | Q43047366 | ||
| Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group | Q43413219 | ||
| Risk factors for hepatocellular carcinoma in Turkey | Q43600136 | ||
| Toward prevention of hepatocellular carcinoma developing in chronic hepatitis C. | Q43669336 | ||
| Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000 | Q43795768 | ||
| Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany | Q44248442 | ||
| Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis | Q44324963 | ||
| Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. | Q44830599 | ||
| Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors | Q45245806 | ||
| Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma | Q45387415 | ||
| Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome | Q45406546 | ||
| Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. | Q45464123 | ||
| High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. | Q45751000 | ||
| The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection | Q45767543 | ||
| A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. | Q45849284 | ||
| P433 | issue | 1 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| Middle East | Q7204 | ||
| P304 | page(s) | 31-41 | |
| P577 | publication date | 2010-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Middle East journal of digestive diseases | Q26842209 |
| P1476 | title | Hepatocellular carcinoma in the world and the middle East | |
| P478 | volume | 2 |
| Q36029549 | Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010. |
| Q34135081 | Case 1-2011: a 26 year-old man with right lower limb edema and liver mass |
| Q33597400 | Common Digestive and Liver Diseases among 5880 Patients Admitted to Shariati Hospital,Tehran,Iran during 2000-2009 |
| Q60936575 | Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma |
| Q37625766 | Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis |
| Q35790424 | Hepatocellular carcinoma in Asia: Prevention strategy and planning |
| Q28086834 | Immune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DP |
| Q35837866 | Inhibitory Effect of Genistein on PLC/PRF5 Hepatocellular Carcinoma Cell Line |
| Q34653639 | Non-viral factors contributing to hepatocellular carcinoma |
| Q36383818 | Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia. |
| Q89860461 | Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues |
| Q58696470 | Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents |
| Q38712052 | Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line. |
| Q54091462 | The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population |
| Q38246790 | The importance of hepatitis B virus genome diversity in Basal core promoter region. |
| Q42277757 | Transarterial chemoembolization for the treatment of hepatocellular carcinoma: A single center experience including 221 patients |
| Q36029543 | Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010. |
| Q43165926 | Undiagnosed Hepatocellular Carcinoma Presenting as Nasal Metastases |
| Q37031741 | Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors |
Search more.